» Articles » PMID: 19898681

C-Fos and PERK, Which is a Better Marker for Neuronal Activation and Central Sensitization After Noxious Stimulation and Tissue Injury?

Overview
Journal Open Pain J
Date 2009 Nov 10
PMID 19898681
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

c-Fos, the protein of the protooncogene c-fos, has been extensively used as a marker for the activation of nociceptive neurons in the spinal cord for more than twenty years since Hunt et al. first reported that peripheral noxious stimulation to a hind paw of rats leads to a marked induction of c-Fos in superficial and deep dorsal horn neurons in 1987. In 1999, Ji et al. reported that phosphorylated extracellular signal-regulated kinase (pERK) is specifically induced by noxious stimulation in superficial dorsal horn neurons. Accumulating evidence indicates that pERK induction or ERK activation in dorsal horn neurons is essential for the development of central sensitization, increased sensitivity of dorsal horn neurons that is responsible for the generation of persistent pain. Further, molecular mechanisms underlying ERK-mediated central sensitization have been revealed. In contrast, direct evidence for c-Fos-mediated central sensitization is not sufficient. After a noxious stimulus (e.g., capsaicin injection) or tissue injury, c-Fos begins to be induced after 30-60 minutes, whereas pERK can be induced within a minute, which can correlate well with the development of pain hypersensitivity. While c-Fos is often induced in the nuclei of neurons, pERK can be induced in different subcellular structures of neurons such as nuclei, cytoplasma, axons, and dendrites. pERK can even be induced in spinal cord microglia and astrocytes after nerve injury. In summary, both c-Fos and pERK can be used as markers for neuronal activation following noxious stimulation and tissue injury, but pERK is much more dynamic and appears to be a better marker for central sensitization.

Citing Articles

Modulation of pain sensitivity by Ascl1- and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice.

Hwang S, Rahman M, Go E, Roh J, Park R, Lee S Mol Ther. 2025; 33(2):786-804.

PMID: 39741412 PMC: 11852955. DOI: 10.1016/j.ymthe.2024.12.039.


Lateral lamina V projection neuron axon collaterals connect sensory processing across the dorsal horn of the mouse spinal cord.

Browne T, Smith K, Gradwell M, Dayas C, Callister R, Hughes D Sci Rep. 2024; 14(1):26354.

PMID: 39487174 PMC: 11530558. DOI: 10.1038/s41598-024-73620-4.


Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases.

Zheng K, Chen M, Xu X, Li P, Yin C, Wang J Cell Mol Biol Lett. 2024; 29(1):134.

PMID: 39472796 PMC: 11523778. DOI: 10.1186/s11658-024-00653-y.


Oxytocin Receptors on Calvarial Periosteal Innervation: Therapeutic Target for Post-Traumatic Headache?.

Bharadwaj V, Klukinov M, Cowan R, Mahinparvar N, Clark D, Yeomans D Pharmaceutics. 2024; 16(6).

PMID: 38931882 PMC: 11206786. DOI: 10.3390/pharmaceutics16060760.


SIRT1-regulated ROS generation activates NMDAR2B phosphorylation to promote central sensitization and allodynia in a male chronic migraine rat model.

Zhang X, Zhang W, Wang Y, Zhang Y, Zhang D, Qin G Front Mol Neurosci. 2024; 17:1387481.

PMID: 38840778 PMC: 11150646. DOI: 10.3389/fnmol.2024.1387481.


References
1.
Rauscher 3rd F, Sambucetti L, Curran T, Distel R, Spiegelman B . Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell. 1988; 52(3):471-80. DOI: 10.1016/s0092-8674(88)80039-4. View

2.
Ji R, Baba H, Brenner G, Woolf C . Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999; 2(12):1114-9. DOI: 10.1038/16040. View

3.
Adwanikar H, Karim F, Gereau 4th R . Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain. 2004; 111(1-2):125-35. DOI: 10.1016/j.pain.2004.06.009. View

4.
Kingery W, Agashe G, Sawamura S, Davies M, Clark J, Maze M . Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression. Anesth Analg. 2001; 92(2):476-82. DOI: 10.1097/00000539-200102000-00037. View

5.
Hunter J, Woodburn V, DURIEUX C, Pettersson E, Poat J, Hughes J . c-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression. Neuroscience. 1995; 65(2):485-92. DOI: 10.1016/0306-4522(94)00500-5. View